Clinical Trial Update: Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating losartan for hepatic fibrogenesis in chronic hepatitis C has completed. The study investigated whether losartan could influence liver f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Fibrosis

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Chronic Hepatitis C, Liver Fibrosis | Phase 4 | Status: COMPLETED